ROIV Roivant Sciences Ltd.

NASDAQ
$38.66

Roivant Sciences Ltd. (ROIV) is expected to report earnings on February 8, 2027, before the market open. The consensus earnings estimate is a loss of $0.44 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.1% since its last earnings release on November 9, 2026.

Roivant Sciences Beat Consensus Estimates
Monday, November 9, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Dec 2026
Feb 8
Monday · 7:00 AM ET
Earnings Whisper
-
vs ($0.44)
Rev est $43.14M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $39.92

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Roivant Sciences Ltd.

Roivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.